Pacific Biosciences Of California | PACB - Current Liabilities


Pacific Biosciences Of California reported $68.81M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Agilent USD 2.29B 20M Jun/2026
Bruker USD 1.2B 150.4M Jun/2026
Danaher USD 8.1B 645M Jun/2026
General Electric Aerospace USD 40.43B 403M Jun/2026
Illumina USD 1.58B 12M Jun/2026
Myriad Genetics USD 130.7M 500K Jun/2026
Pacific Biosciences Of California USD 68.81M 3.45M Jun/2026
Quidel USD 993.4M 31M Jun/2026
Revvity USD 1.28B 37.71M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Standard Biotools USD 42.2M 66.1M Mar/2026
Thermo Fisher Scientific USD 15.07B 448M Jun/2026
Waters USD 2.27B 1.03B Mar/2026